Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT03661307
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
73 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Acute Myeloid Leukemia


Myelodysplastic Syndrome


Recurrent Acute Myeloid Leukemia


Recurrent Myelodysplastic Syndrome


Refractory Acute Myeloid Leukemia
COMPLETED
NCT02943993
Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe
2,809 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Venous Thromboembolism
COMPLETED
NCT05774431
Disparities in the Proportion of Ticagrelor and Prasugrel-eligible Patients with Acute Coronary Syndrome in a Real-world Registry
6,789 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Acute Myocardial Infarction
RECRUITING
NCT06727227
Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer
135 Enrollment(s)
14 Study location(s)
OBSERVATIONAL (None)
Breast Cancer
NOT_YET_RECRUITING
NCT06899126
Study of Trastuzumab Deruxtecan in Combination With Pembrolizumab Versus Pembrolizumab With Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
686 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE3)
Non-small Cell Lung Cancer
RECRUITING
NCT05048797
A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations
450 Enrollment(s)
163 Study location(s)
INTERVENTIONAL (PHASE3)
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ACTIVE_NOT_RECRUITING
NCT04639219
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations
102 Enrollment(s)
30 Study location(s)
INTERVENTIONAL (PHASE2)
Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
RECRUITING
NCT05417594
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
490 Enrollment(s)
31 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Advanced Solid Malignancies